Cord Blood America, Inc. Announces Financial Results for the First Quarter Ended March 31, 2018
May 14, 2018 at 08:01 am EDT
Share
Cord Blood America, Inc. announced financial results for the first quarter ended March 31, 2018. For the quarter, the company’s total revenue from discontinued operations was $0.70 million, a decrease of 5.8% from
total revenue of $0.75 million for the first quarter 2017. The decrease was the result of a decrease in new enrollment/processing revenue offset by an increase in recurring storage revenue. Net loss from continuing operations for the was $0.42 compared to a net loss from continuing operations of $0.37 million for the three-month period ended March 31, 2017.
CBA Florida, Inc., formerly Cord Blood America, Inc., through its CorCell program and its subsidiary CorCell Companies, Inc., provides cord blood and cord tissue stem cell services. The Company's subsidiaries include Cord Partners, Inc., CorCell Companies, Inc., CorCell, Ltd., (Cord Partners, Inc., CorCell Companies, Inc. and CorCell, Ltd. are referred to collectively as Cord), CBA Properties, Inc. (Properties), and Career Channel, Inc. The Company and its subsidiaries provides private cord blood and cord tissue stem cell storage services to families throughout the United States and Puerto Rico, and Properties was formed to hold corporate trademarks and other intellectual property. Cord's operations provide umbilical cord blood banking and cord tissue services to expectant parents. Cord provides various services, which includes collection materials, physician and customer support, transportation, testing and cord blood storage.
CBA FLORIDA, INC.